Abstract: PD27-06
Sources of Funding: None

Introduction

In recent years, laser surgery has been widely used to treat benign prostatic hyperplasia (BPH). A thulium laser was recently introduced for BPH surgery. We compared the effectiveness and safety of thulium laser vaporesection of the prostate (ThuVaRP) with that of bipolar transurethral resection of the prostate (TURP).

Methods

From January 2014 to March 2016, 186 patients who were advised TURP for symptomatic BPH were randomized into two groups. We analyzed and compared outcomes of 93 patients who underwent ThuVaRP and 93 patients who underwent bipolar TURP. All patients were assessed by using the International Prostate Symptom Score, transrectal ultrasonography, the serum prostate-specific antigen (PSA) level, uroflowmetry, and postvoid residual volume before and 1 month after surgery. These patients were followed up for six months. All complications and short term outcomes were compared between the two groups.

Results

ThuVaRP was superior to TURP in catheterization time and length of hospital stay. However, operation time was longer with ThuVaRP than with TURP. In patients with a large prostate more then 100 grams, operation time was much longer with ThuVaRP. One month after surgery, the decrease in PSA was greater with ThuVaRP than with TURP, and the increase in maximal urine flow rate was greater with ThuVaRP than with TURP. The postoperative complication transient urinary incontinence was significantly different between the ThuVaRP group (17.6%) and the TURP group (4.2%). Other complications and short term followup results were comparable between both groups._x000D_

Conclusions

The effectiveness and safety of ThuVaRP and TURP were comparable. _x000D_ ThuVaRP is a promising alternative surgical technique to TURP for BPH_x000D_

Funding

None